|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Merck & Co Inc [MRK]
$78.72 0.41 (0.52%)
Market Cap 204.68 Billion
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the company's sales are generated in the United States.
EPS 1.13 P/E Ratio 33.85
Previous Earnings Tue, Apr 30, 2019
Latest Earnings Tue, Jul 30, 2019 (In 72 days)
Yield 2.79% / $2.20
Ex-Date Thu, Mar 14, 2019 (66 days ago)
Pay Date Fri, Apr 5, 2019
This list of trending stocks may change throughout the trading day.